Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
about
Poly(ADP-ribose) polymerase-1 inhibition: preclinical and clinical development of synthetic lethality.New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}Peroxynitrite-driven mechanisms in diabetes and insulin resistance - the latest advancesPoly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.Evaluation of neonatal streptozotocin induced diabetic rat model for the development of cataract.Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat modelRole of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathiesPARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.Wld(S) ameliorates renal injury in a type 1 diabetic mouse model.Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress.Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita miceRole of poly (ADP-ribose)-polymerase and its signaling pathway with renin-angiotensin aldosterone system in renal diseases.PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.Role of poly(ADP-ribose) polymerase activation in the pathogenesis of periodontitis in diabetes.Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor.Inhibition of poly(ADP-ribose) polymerase may have preventive potential for varicocoele-associated testicular damage in rats.
P2860
Q33851843-2194F6D9-2D05-4C37-B8B8-14EA43DF7617Q33874485-DB20757C-E251-40ED-8AEF-286F1CEB1BA5Q34314724-95F6CDD4-76D5-4D58-B66C-D555A7678E79Q34441033-E5216894-A394-4CA5-952E-589DC3FBBE79Q34620839-78863C3A-E901-4593-93F1-A965BF0AB28CQ34653233-C3E01341-2CA1-4413-9080-7F0945CB9FAFQ34667363-3E5871A0-B1A9-4009-9CC7-3C17BE2AE69CQ34851871-56C8BF91-8F94-4F4E-BD0E-D29477A24C93Q35112034-02DA6F89-2E65-4821-B1A1-32A12D37E117Q35762675-291841B9-3F03-486A-AE8F-48D50DBE1A67Q36032110-3C4878E5-9CD2-411A-8D61-38A545847ADCQ38168567-A0D66297-6901-42CF-AAF8-9A1D710513D3Q38754677-62B01AFE-A311-4A45-A754-8EE7D489A974Q48344437-038150A7-1AF8-4B20-A378-B1EC88C707BAQ50679885-475A3E41-A0D0-4270-BCEE-D92A5A52F45CQ51250810-09172C98-B7B1-4B42-B474-FE9190A60BAC
P2860
Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Poly(Adenosine 5'-diphosphate- ...... l type 1 diabetic nephropathy.
@en
type
label
Poly(Adenosine 5'-diphosphate- ...... l type 1 diabetic nephropathy.
@en
prefLabel
Poly(Adenosine 5'-diphosphate- ...... l type 1 diabetic nephropathy.
@en
P2093
P2860
P356
P1433
P1476
Poly(Adenosine 5'-diphosphate- ...... al type 1 diabetic nephropathy
@en
P2093
Barbara Slusher
Irina G Obrosova
Ivan A Pavlov
Weizheng Xu
P2860
P304
P356
10.1210/EN.2009-0628
P407
P577
2009-10-23T00:00:00Z